# Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus

> **NCT00353691** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 100 (—)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** glimepiride
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT00353691
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** —
- **Final completion:** 2004-11
- **Target enrollment:** 100 (—)
- **Last updated:** 2011-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00353691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00353691, "Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00353691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*